Initial Hospital Contact for Alcohol Issues Predicts Cirrhosis

Share this content:
Initial Hospital Contact for Alcohol Issues Predicts Cirrhosis
Initial Hospital Contact for Alcohol Issues Predicts Cirrhosis

WEDNESDAY, Nov. 23, 2016 (HealthDay News) -- An initial hospital contact for alcohol problems is a significant predictor of alcoholic liver cirrhosis, particularly for patients 40 to 59 years and those diagnosed with harmful use or dependence, according to a study published online Nov. 16 in Hepatology.

Gro Askgaard, M.D., from Copenhagen University Hospital in Denmark, and colleagues followed all Danish patients with an initial hospital contact for alcohol problems during 1998 to 2002 for development of alcoholic liver cirrhosis (36,044 patients). The authors examined predictors of the absolute risk for alcoholic liver cirrhosis.

The researchers found that in men and women, age and alcohol diagnosis were significant predictors of alcoholic liver cirrhosis risk, while civil status, education, and type of hospital care were not. The 15-year absolute risks were 0.7, 5.5, 9.8, 8.9, 6.2, and 2.5 percent, respectively, for men aged 20 to 29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, and 70 to 84. According to alcohol diagnosis, the 15-year absolute risks in men were 2.6, 7.7, and 8.8 percent, respectively, for intoxication, harmful use, and dependence. Relative to the general population, the incidence rate ratio for alcoholic liver cirrhosis in the cohort was 11 in men and 18 in women.

"Hospital patients with alcohol problems had a much greater risk for alcoholic liver cirrhosis compared to the general population," the authors write. "The risk was particularly increased for patients 40 to 59 years and for patients diagnosed with harmful use or dependence."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »